Threat Intelligence Brief
Curated summary with source attribution
Source: reuters.com
Threat Risk: High
Victim: Amgen
Incident: Unauthorized access and theft of patient information.
Impact: Potential exposure of sensitive personal health information and regulatory non-compliance.
Attacker: Unidentified threat actors
Analysis: The incident involves the unauthorized access and theft of patient information from Amgen’s environment. This breach emphasizes the high value of pharmaceutical and clinical data to threat actors. The exposure of personal health information (PHI) typically leads to significant regulatory scrutiny and privacy risks.
Recommendations: Implement strict zero-trust access controls for all databases containing patient information; Conduct a thorough audit of API endpoints and third-party integrations for potential leak points; Enhance encryption for sensitive data at rest to mitigate the impact of future exfiltration
Source: Reuters
Editorial note: this post summarizes third-party reporting and links to the original source.
View Original Source